Bioactivity:

Etalocib is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase. It has antineoplastic activities.

CAS nr:

161172-51-6

Purity:

98%

Molecular Weight:

544,6

SMILES:

O=C(O)C1=CC=CC=C1OC2=CC=CC(OCCCOC3=C(CC)C=C(C4=CC=C(F)C=C4)C(O)=C3)=C2CCC

Formula:

C33H33FO6

Pathway:

Immunology/Inflammation,GPCR/G Protein,Apoptosis

Target:

LTR,Leukotriene Receptor,Apoptosis